mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.03 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.03 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.03 |
mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.03 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.03 |
mRNA |
CCT007093 |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.03 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |